| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1969 |
| Trial ID | NCT03666000 |
| Disease | B-Cell Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PBCAR0191 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Dose-escalation, Dose-expansion Study of Safety of PBCAR0191 in Patients With r/r NHL and r/r B-cell ALL |
| Year | 2018 |
| Country | United States |
| Company sponsor | Precision BioSciences, Inc. |
| Other ID(s) | PBCAR0191-01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||